Neural transplantation is developing into a therapeutic alternative in Parkinson's disease. A major limiting factor is that only 3-20% of grafted dopamine neurons survive the procedure. Recent advances regarding how and when the neurons die indicate that events preceding actual tissue implantation and during the first week thereafter are crucial, and that apoptosis plays a pivotal role. Triggers that may initiate neuronal death in grafts include donor tissue hypoxia and hypoglycemia, mechanical trauma, free radicals, growth factor deprivation, and excessive extracellular concentrations of excitatory amino acids in the host brain. Four distinct phases during grafting that can involve cell death have been identified: retrieval of the embryo; dissection and preparation of the donor tissue; implantation procedure followed by the immediate period after graft injection; and later stages of graft maturation. During these phases, cell death processes involving free radicals and caspase activation (leading to apoptosis) may be triggered, possibly involving an increase in intracellular calcium. We review different approaches that reduce cell death and increase survival of grafted neurons, typically by a factor of 2-4. For example, changes in transplantation procedure such as improved media and implantation technique can be beneficial. Calcium channel antagonists such as nimodipine and flunarizine improve nigral graft survival. Agents that counteract oxidative stress and its conse quences, such as superoxide dismutase overexpression, and lazaroids can significantly increase the survival of transplanted dopamine neurons. Also, the inhibition of apoptosis by a caspase inhibitor has marked posi tive effects. Finally, basic fibroblast growth factor and members of the transforming growth factor-beta superfamily, such as glial cell line-derived neurotrophic factor, significantly improve the outcome of nigral transplants. These recent advances provide hope for improved survival of transplanted neurons in patients with Parkinson's disease, reducing the need for human embryonic donor tissue and increasing the likelihood of a successful outcome.
A LOW SURVIVAL RATE OF GRAFTED DOPAMINE NEURONS: BIOLOGICAL CHALLENGE AND CLINICAL PROBLEM
kinson's disease patient (88) that the issue of improving the survival of grafted dopamine neurons attained high priority. Indeed, as evidenced by positron emission to mography using fluorodopa as a ligand, robust clinical improvement in patients receiving transplants is be lieved to depend upon restoration of a high degree of dopaminergic striatal neurotransmission (64) . Of course, other factors may be important for the clinical outcome, such as the age of the patient, disease duration, severity of underlying dopaminergic denervation, and the pres ence of nondopaminergic lesions. Nonetheless, clinical findings stressing the importance of a restoration of stri atal neurotransmission in Parkinson's disease patients receiving grafts are in agreement with results from ex periments in rats indicating a correlation between behav ioral effects and graft survival [for review see (18) ]. It Already in 1987 (16) it was proposed that only around 10% of grafted rat dopaminergic neurons survive intracerebral transplantation, and several studies since then have confirmed that the survival rate is in the range of 1 -20% (Tables 1 and 2 ). Although these early obser vations identified an interesting biological problem, the poor survival of grafted dopaminergic neurons did not constitute a major practical problem in experimental set tings where it was possible to simply increase the amount of implanted tissue by using more donors. It was not until it was shown that nigral implants from several human embryos gave rise to functional effects in a Par- .6%
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The figures are either those stated by the respective authors or have been computed based on data presented in the publication. The computations are based on either one of the two following assumptions: "there are around 35,000 dopamine neurons (tyrosine hydroxylase positive, TH+) in one rat embryonic mesencephalon; b around 8% of the cells in dissected embryonic rat mesencephalic tissue are dopaminergic. This implies that there are around 400,000 cells obtained from each dissected ventral mesencephalon.
is believed that significant clinical improvement in Par kinson's disease patients requires that the transplant is derived from ventral mesencephalic tissue from [4] [5] [6] [7] [8] aborted embryos per side of the brain. The need for mul tiple donors for each patient represents a limiting step in many clinical trials (134) . Considering that the survival rate of grafted human dopaminergic neurons is believed to be around 5-10%, based on data from xenografts to immunosuppressed rats (23, 54) and postmortem find ings in Parkinson's disease patients receiving grafts 
HOW CAN THE SURVIVAL RATE OF GRAFTED DOPAMINE NEURONS BE CALCULATED?
When attempting to increase the survival of trans Also there may be significant differences in the number of dopaminergic neurons in male and female rat em bryos (10) . Moreover, there may be a higher number of dopaminergic neurons in the embryo than estimated for the adult, because some nigral neurons are believed to undergo programmed cell death before the rat reaches adulthood (75, 137) .
In the second approach, the number of transplanted mesencephalic cells is monitored by assessing the con centration of cells in the graft suspension (19) and not ing the volume of cell suspension grafted to each host.
Based on immunocytochemical studies of fresh smears of mesencephalic cell suspensions, it is estimated that the proportion of dopaminergic (tyrosine hydroxylasepositive) neurons is 8-10% in embryonic rat (115) Tables 1 and 2 we state the method we have used to calculate survival of transplanted dopamine neurons, based on information about the grafting procedure presented in each respec tive study.
WHEN DO TRANSPLANTED NEURONS DIE?
Grafted embryonic dopamine neurons may die during one of at least four phases that encompass the transplan tation procedure and time during which the nigral trans plant develops in the host brain ( Fig. 1 ). First, the hyp oxic and hypoglycemic insult caused by removing the donor embryo from its maternal blood supply is likely to cause oxidative damage (58) . Second, the axotomy during dissection and the other traumatic damage caused by mechanical dissociation, as well as the hypoxia dur ing the delay before implantation into the host brain, are also possible culprits in the neuronal damage. Third, the actual implantation procedure and the immediate period to the adult nervous system (5, 89) , and the expression of potentially damaging inflammatory cytokines as a re sult of the brain damage (57) . Fourth, it is conceivable that there is cell death due to a lack of appropriate neuro trophic support at a later stage when the embryonic neu rons slowly mature in the new host environment (45) .
Based on results from in vitro culture experiments, Fawcett et al. (49) proposed that around 30% of the em bryonic dopamine neurons die already during the me chanical dissociation step of the donor tissue preparation (phase 2, Fig. 1 ). This is consistent with accumulating experimental evidence indicating that the majority of do paminergic neurons grafted as dissociated cell suspen sions die before implantation and within the first week after surgery (8, 37, 42, 81, 102) . This evidence stems from 
CHANGES IN TRANSPLANTATION TECHNIQUE TO IMPROVE TRANSPLANT SURVIVAL
This review is primarily focused on studies aimed at improving mesencephalic transplant survival by direct addition of growth factors and neuroprotective agents to nigral donor tissue. Therefore, we mostly describe stud ies where the donor embryos were of an optimal devel opmental stage for obtaining nigral tissue. In rats, this is equivalent to an embryonic age of around 13-15 days (with the day of mating considered as day 0) when graft ing dissociated tissue [for review see (22) ], and can be extended up to day 17 when grafting solid pieces of mesencephalon (125) . However, even when using em bryonic tissue of an optimal donor age, there are several modifications in basic transplantation methodology that can affect graft survival and that deserve to be men tioned briefly. First, choice of medium for dissection and tissue preparation is of importance. During the 1980s, most experiments involving nigral cell suspen sion transplantation employed a simple, unbuffered glu cose-saline medium to prepare and dissociate the trans plant tissue (12) . Over recent years there has been a move towards using more balanced media, such as Hank's balanced salt solution (HBSS). When nigral cell suspensions are stored at room temperature and in vitro cell viability is assessed, it is evident that a high cell viability is maintained for longer time periods when the cells are kept in HBSS instead of glucose-saline (101) . Recently, Bjorklund et al. (13) found that solid nigral transplants placed in the anterior chamber of the eye sur vive better if the culture medium Dulbecco's modified Eagle medium (DMEM), as opposed to HBSS, is used when harvesting and injecting the tissue. Congruent with these findings, it has recently been demonstrated that grafts of dissociated mesencephalic tissue survive im plantation into the striatum significantly better when they are prepared in DMEM than in HBSS (141) . With respect to cell suspension transplants, the degree of tis sue dissociation is another important factor influencing graft survival (9, 19) . In a direct comparison, Watts et al. (142) observed improved survival when the nigral donor tissue was grafted intrastriatally as small tissue blocks, compared to when it was mechanically dissociated into a cell suspension. It seems that excessive mechanical dissociation of donor tissue by repeated and vigorous trituration through the tip of a pipette, until a single cell suspension is obtained, can cause irreparable damage to the cells, and that a mixture of small aggregates and single cells may be a better alternative (9) . Furthermore, it is conceivable that maintaining some degree of the normal structure within the grafted tissue piece may pro mote the formation of appropriate and functional neu ronal connections within the graft and with the host brain. Finally, as mentioned previously, Fawcett and co workers (49) have estimated that around 30% of the em bryonic dopamine neurons die when the mesencephalon is dissociated into a single cell suspension.
In an attempt to minimize host brain damage, Nikkhah and coworkers modified a micrografting technique (44) and injected nigral cell suspensions into, for exam ple, the striatum. In their detailed methodological de- 
MECHANISMS THAT MEDIATE CELL DEATH IN TRANSPLANTED NEURONS AND EFFECTS OF PHARMACOLOGICAL INTERVENTIONS
Cell death is currently considered to occur according to one of two patterns: necrosis or apoptosis, although intermediate forms exist (110) . Both processes are likely to play an important role in cell death that accompanies embryonic neuronal transplantation (Fig. 2 ). Necrotic cell death is typically the result of an pathological event and follows an insult severe enough to cause irreversible cellular dysfunction and energy deprivation. Usually ne crotic cell death is a fast process, occurring in minutes to hours and is finally characterized by cell and organelle swelling and plasma membrane permeabilization, fol lowed by an inflammatory reaction in the surrounding tissue [for review see (84) ]. In contrast, apoptotic cell death (including programmed cell death) is typically a slow, controlled, energy-and protein synthesis-depen dent process lasting a period of hours to days [for review see (84) ]. Apoptosis occurs naturally during the devel opment of the nervous system (107, 112) but has also been implicated in ischemia and many neurodegen erative diseases (15 85 Neuronal injury is often associated with a sustained elevation of intracellular calcium and an increased oxi dative stress (27, 85, 108) , conditions that are likely to prevail also in grafted neurons. Normally, cytosolic cal cium is buffered by mitochondria and the endoplasmic reticulum, as well as by several calcium binding proteins (71, 108) . Calcium homeostasis is further controlled by extrusion mechanisms over the outer plasma membrane.
A shortage of energy, as may occur in neural transplants, can lead to reduced calcium extrusion and make it im possible for the cell to uphold a plasma membrane po tential, which in turn results in release of glutamate from the depolarized neuron into the surrounding extracellular space (86) . As a result, there is excessive stimulation of ionotropic excitatory amino acid receptors with concom itant increased calcium entry and overload of mitochon dria, free radical generation, and activation of several potentially detrimental enzymes, including phospholipases, proteases, and nitric oxide synthase (NOS) (86) (Fig. 2 ). This form of neuronal cell death has been termed "excitotoxicity" (106) and will be addressed in more detail in a later section.
Oxidative stress is a consequence of disturbed ho meostasis between production and scavenging of re- (128)]. Superoxide radicals are also formed by, for example, activated microglia (30) . Superoxide can generate new reactive oxygen species via dismuta-tion to hydrogen peroxide followed by subsequent reac tion with iron to form hydroxyl radicals. Alternatively, superoxide reacts with nitric oxide to form peroxynitrite, which is highly toxic to several cellular components (111) . Nitric oxide is produced by nitric oxide synthase (NOS), which is a calcium-activated enzyme. Interest-ingly, auto-and enzymatic oxidation of dopamine also leads to the generation of superoxide and hydrogen per oxide (76) . Therefore, it has been proposed that dopa minergic neurons are more likely to be subjected to oxi dative stress than other neuronal cell types (104) .
Lack of growth
During normal development and adult life, dopamin ergic neurons are known to respond to several types of growth factors (45) . Loss of neurotrophic support can lead to neuronal death both in developing and adult brains, and may be an important trigger of cell stress in grafted embryonic dopamine neurons. Intracellular sig naling leading to death of neurons deprived of growth factors is not fully understood, but a complex series of events is likely to lead to the apoptosis in deprived cells (35, 36) .
In the following four sections of this article we re view interventions aimed at reducing neuronal death in grafts and that have focused on different, but still con nected, cell death mechanisms: a) calcium and excito toxicity; b) oxidative stress; c) caspase activation and apoptosis; d) lack of trophic support.
Excitotoxicity and Neuronal Death in Nigral Transplants
Of the three major classes of ionotropic glutamate receptors known in the brain: Af-methyl-D-aspartate (NMDA) receptors, a-amino-3-hydroxy-5-methylisoxazole-4-proprionate (AMPA)/kainate (KA) receptors, and metabotropic receptors, it is believed NMDA receptors play the most prominent role in excitotoxicity, although the other receptor subtypes may also contribute to cell death (32) . Furthermore, there are three different types of voltage-dependent calcium channels (VDCC) present in neurons, called T-, L-, and N-channels (94) , that can also be involved in calcium-mediated toxicity.
Excitotoxic neuronal death may be induced in nigral transplants during the retrieval and dissection of embry onic donor brain tissue (phases 1 and 2 in Fig. 1 ) and by the surgical procedure itself (phase 3 in Fig. 1) (28,95) . These findings suggest that cell death occurring during phase 2 (Fig. 1 ) of the nigral transplantation protocol is not primarily due to excitotoxicity mediated via the NMDA receptor.
Nimodipine, a calcium channel blocker, has been shown to enhance the growth and vascularization of in trastriatal nigral grafts when administered intragastric-ally to transplant recipients (52) . However, this positive effect on graft survival was only apparent either when the donors were older than considered optimal, or, alter natively, donor tissue of an optimal age had been stored for several hours at room temperature before implanta tion. More recently, we have found that flunarizine, an antagonist of L-, T-, and N-type calcium channels shown to protect against oxidative stress and lipid per oxidation in brain cells (136) .
Reducing Oxidative Stress in Nigral Transplants
Most reactive oxygen species are free radicals, such as hydroxyl (HO*), superoxide (0 2 *), and nitric oxide (NO*) radicals, but there are also nonradical species such as hydrogen peroxide (H 2 0 2 ) and peroxynitrite (ONOO) (Fig. 2) . The hydroxyl radical is the most reactive oxy gen species and is the main mediator of oxidative dam age. For example, hydroxyl attack on DNA leads to strand breaks and base modifications, and attack on pro-teins can lead to impaired cellular function (53) . Finally, attack by reactive oxygen species on lipid membranes leads to generation of lipid radicals and a chain reaction of lipid peroxidation is initiated (66) . We will describe two principally different methods to counteract oxida tive stress in grafted neurons. First, we discuss inter ference with the formation of specific radicals (e.g., by enhancing naturally occurring antioxidant systems). Sec ond, we describe agents that either disarm reactive oxy gen species in a nonspecific fashion or inhibit the propa gation of radical reactions that mediate cell-damaging processes.
Superoxide dismutase (SOD) catalyses the conver sion of superoxide to hydrogen peroxide. There are three isoforms of SOD, of which Cu/Zn SOD has been sug gested to contribute the most to the dismutase activity in the brain. In order to evaluate the role of Cu/Zn SOD in transplantation of dopaminergic neurons, we used em bryonic ventral mesencephalic tissue from transgenic mice overexpressing human Cu/Zn SOD as donor tissue (99) . Tissue from transgenic or nontransgenic littermates was transplanted into adult rats. We observed an average increase in the survival of dopaminergic neurons to 400% of mean control value, and the striatal area in the host reinnervated by the grafts was found to be 6.5 times higher in the transgenic group compared with the control (99) . However, using adenoviral transfer of the human gene for Cu/Zn SOD, as an alternative approach to de liver SOD, did not significantly increase the survival of grafted rat nigral neurons (7) . This was possibly due to relatively low proportion of the grafted cells being trans duced by the adenoviral infection (7) .
The cell permeant synthetic compound, Mn(III)tetrakis (4-benzoic acid) porphyrin (MnTBAP), has been suggested to have similar dismutase action as endoge nous SOD (48, 80) . However, in addition to scavenging superoxide, MnTBAP has been reported to also scav enge hydrogen peroxide (33) and peroxynitrite anion (133) . In a recent pilot study, we observed an approxi mate doubling in the number of surviving dopaminergic neurons in mesencephalic transplants when MnTBAP was added to the implanted nigral cell suspension during phase 2 of the procedure (Fig. 1) (41) . In the cell, both glutathione peroxidase and catalase can further process the product of superoxide dismutation and convert hy drogen peroxide to water. In a pilot study, we recently examined the effects of catalase as a potentially protec tive agent in grafts. Indeed, the addition of catalase to the cell suspension resulted in more than twice as many surviving dopamine neurons in the grafts (41) .
In order to evaluate the role of nitric oxide in trans plants, Van Muiswinkel and coworkers treated mesence phalic cell suspensions and graft recipients with the NOS inhibitor A^-nitro-Z-arginine methylester (L-NAME) (140) . It was found that L-NAME given to cell suspen sions alone (phase 2) or to both cell suspension and graft recipients (phases 2-4) did not enhance the survival of transplanted dopaminergic neurons in comparison to control transplanted rats. Taken together, these experi ments indicate that superoxide and hydrogen peroxide contribute to death of transplanted dopaminergic neu rons. Because inhibition of NOS did not have an effect on neuronal survival, but treatment with catalase did, it could be speculated that superoxide radical primarily ex erts its toxic effects via conversion to hydrogen peroxide and not via peroxynitrite formation.
While the experiments described above may eventu ally help to elucidate which radical-forming pathways are most important during the death of grafted dopamine neurons, it is also possible that a nonspecific inhibition of radical reactions could be beneficial to graft survival.
Spin-trap agents are a class of agents that react with free radicals to form more stable and less reactive adducts.
The spin-trap agent most commonly used to prevent neuronal damage is oc-phenyl-Af-tert-butyl nitrone (PBN), which, for example, can reduce ischemic damage in gerbils and rats (26, 105, 145) and protect striatal neurons from excitotoxic lesions (100, 124) . However, PBN does not increase the survival of transplanted dopaminergic neurons when given to the graft recipient before and during the first 24 h after transplantation (phase 3, Fig.   1 ), or when added to the cell suspension (phase 2, Fig.   1 ) (78) .
Lipid peroxidation is another radical-mediated pro cess that is possible to pharmacologically inhibit. The main initiator of lipid peroxidation is the hydroxyl radi cal, which abstracts a hydrogen from membrane lipids, generating lipid radicals and starting a chain reaction of free radical damage [see (66) ]. This leads to formation of toxic by-products (such as malondialdehyde and 4hydroxynonenal), disruption of membrane integrity, in ability to maintain ion homeostasis, and ultimately cell death (92) . Lazaroids are a group of compounds specifi cally designed to inhibit lipid peroxidation [for review see (65) ]. The first generation of lazaroids, 21-aminosteroids, scavenge radicals and also interact directly with cell membranes to decrease membrane fluidity (14) . The most known 21-aminosteroid, tirilazad mesylate (U-74006F), has been investigated in a transplantation para digm where intact pieces of ventral mesencephalon were grafted into the anterior chamber of the eye (13) .
Whereas tirilazad treatment during dissection only (61), and serum deprivation (55, 78) .
In a transplantation experiment, U-83836E was injected to the pregnant rat, during phase 1 of the transplantation procedure (Fig. 1) , and added to all the solutions during tissue dissociation and immediately thereafter, equiva lent to phase 2 (Fig. 1) . This treatment increased the survival of transplanted dopaminergic neurons to 265%
of control values (98) . In another transplantation study, U-83836E increased the survival to 170% of mean con trol values when present only during the dissection pro cedure and onwards (i.e., phase 2) ( Fig. 1) (79) . Pyrrolopyrimidines are a novel group of lazaroids specifically designed to penetrate the blood-brain barrier more eas ily than tirilazad and U-83836E. Moreover, pyrrolopyrimidines are less membrane-bound than the other lazar oids and can therefore more effectively get access to the intracellular space (65) . Even though the pyrrolopyri- where tirilazad and U-83836E are more likely to insert into the membranes than pyrrolopyrimidines.
Reducing Apoptosis in Nigral Transplants
As previously mentioned, most of the dopaminergic neurons in nigral grafts die during tissue preparation or within 1-4 days after transplantation (37, 42, 77, 102, 150) and it has been shown that at least part of this cell death is apoptotic (90, 119, 150) .
A family of proteases, called caspases, has been shown to play a central role in the apoptotic process ( Fig. 2) (110, 130) . Hitherto, 14 different caspases have been identified. Caspases participate in a cascade of events that is triggered in response to pro-apoptotic sig nals and culminates in cleavage of specific proteins, in cluding proteins involved in fragmentation and repair of DNA, and maintenance of cell morphology (Fig. 2 ) (110, 130) . Caspases can be divided into two groups: ef fector caspases that function in cell disassembly, and ini tiator caspases that are important in initiating this disas sembly in response to pro-apoptotic signals. Inhibitors of caspases have been shown to effectively block neu ronal apoptosis in many different experimental para digms, including growth factor withdrawal (97), excito toxicity (85) , axotomy (34) , cerebral ischemia (69) , and brain trauma (143) .
In a recent study we investigated the effects of the caspase inhibitor Ac-YVAD-cmk on the survival of do paminergic neurons (119) . In a first set of experiments we showed that Ac-YVAD-cmk significantly increased Proteins of the bcl-2 family play a central role in the regulation of caspase activation and therefore in the apoptotic process (1, 110) . The members of the bcl-2 family are either anti-apoptotic, like Bcl-2 ( Fig. 2) and
Bcl-X L , or pro-apoptotic, like Bax. Indeed, transgenic mice expressing human Bcl-2 exhibit reduced apoptosis due to axotomy (38, 47) , ischemia (91), or neurotoxins (103, 144) . In a recent study we found that cultured do paminergic neurons from transgenic mice expressing hu man Bcl-2 were protected from death induced by serum deprivation or exposure to staurosporine (121) . How-ever, expression of human Bcl-2 did not increase the survival of dopaminergic neurons transplanted to rats.
The absence of protection of nigral grafts by overexpres sion of Bcl-2 may be due to one of the following mecha nisms: (a) Bcl-2 may be functionally inactivated in transplanted neurons; (b) an increased expression of Bcl-2 may not be enough to inhibit the activation of caspases normally regulated by Bcl-2 due to very strong proapoptotic signals; (c) cell death mechanisms that are unique to transplanted neurons may bypass a potential block by Bcl-2 (Fig. 2) . Taken together, these results imply that at least a part of the cell death of transplanted dopamine neurons is apoptotic and dependent on activa tion of caspases.
Enhancing Nigral Transplant Survival by Growth Factor Treatment
Prior to the modern era of neurotrophic factors and the identification of several growth factors that are active specifically on dopaminergic neurons, several studies used striatal target cells as a source of trophic support for nigral dopaminergic neurons. Cell culture studies [for review see (6) ] revealed that striatal cells can influence the maturation and biochemistry of embry onic dopamine neurons. When this approach is applied to the neural transplantation paradigm, it is reported that addition of embryonic striatal cells to the implants can induce trophic effects, expressed as an enhanced fiber outgrowth from grafted dopaminergic neurons (20, 31, 43, 148) . Nevertheless, the vast majority of studies indicate that the survival of the grafted dopaminergic neurons is not improved (20, 31, 43, 148) , although there are excep tions to this view (129) . In conclusion, it seems that the addition of embryonic striatal target tissue is not a reli able way to increase the survival of transplanted dopa mine neurons.
Three different families of growth factors have been investigated regarding their effects on transplanted do pamine neurons: the fibroblast growth factor family, the transforming growth factor-beta (TGF-P) family, and the neurotrophins.
Basic fibroblast growth factor (bFGF) was found in 1989 to promote the survival and development of mes encephalic neurons in vitro (50) . The effect is consid ered to be mediated via glial cells (46) , but the precise underlying mechanism for the survival-promoting effect on dopaminergic neurons is not known. In a pioneering article on the effects of bFGF on nigral grafts, the growth factor was administered either as pretreatment (phase 2, Fig. 1 (151) . In this case, the bFGF-induced enhancement of survival was accompanied by a marked increase in the number of activated astrocytes in the implants, suggesting that bFGF does indeed exert its effect via stimulation of glial cells, also in nigral grafts (151) . A secretory form of FGF, kFGF, has been found not to enhance the survival of grafted dopaminergic neu rons (67) .
Glial cell line-derived neurotrophic factor (GDNF), a member of the TGF-P superfamily, was found in 1993
to promote the survival and differentiation of embryonic midbrain cultures (87) . GDNF acts via GDNF family of receptors (GFR) al (25) , but the precise mechanism of action of GDNF on dopaminergic neurons is not known.
Data from in vitro studies indicate that GDNF reduces the amount of apoptosis of embryonic (29) and postnatal dopaminergic neurons (24) . Repeated injections of GDNF adjacent to the intrastriatal nigral grafts every 1-3 days for 10-21 days increase the survival and fiber outgrowth of the dopaminergic neurons (114, 127) . Several other protocols for delivery of GDNF to grafts have also been employed successfully. Sullivan and coworkers (131) only added GDNF to the cell suspension (phase 2, Fig.   1 ) and still observed a significant increase in the number However, when mesencephalic neurons are pretreated with GDNF in a hibernation medium at 4°C for 6 days prior to dissociation and then are grafted either in the presence (4) or absence (96) of GDNF in the medium, there are no major effects of GDNF on graft survival.
These results indicate that GDNF is not effective when the cell metabolism is reduced due to the lowered tem-perature (21) . Another member of the TGF-p superfam ily, growth/differentiation factor 5, has recently been shown to be as effective as GDNF at enhancing the sur vival of mesencephalic grafts when added to the cell suspension (131) . Finally, neurturin, a new member of the GDNF ligand family (83) , has been shown to in crease the survival of dopaminergic neurons both in cul tures (72) and in grafts (113) .
Also, members of the neurotrophin family [e.g., brain-derived neurotrophic factor (BDNF) and neurotrophin-4/5 (NT4/5)] have been shown to promote the survival of dopaminergic neurons in vitro (73, 130) .
These neurotrophic factors act through stimulation of the receptors of the trk family, which have been shown to be present on dopaminergic neurons (74) . In the case of nigral transplants none of the neurotrophin family mem bers tested [i.e., nerve growth factor (NGF) (116, 151) , BDNF (116, 149) , NT3 (68), and NT4/5 (68) ] have been found to enhance the survival of implanted mesence phalic dopamine neurons (Table 2 ). However, BDNF (116, 149) and NT4/5 (68) increase the fiber outgrowth from grafted nigral neurons. Even though there is no increase in the survival of grafted dopaminergic neurons following treatment with these factors, their ability to enhance fiber outgrowth may still be important in at tempts to improve nigral transplant function.
To summarize, the growth factors bFGF, GDNF, growth/differentiation factor 5, and neurturin are all ca pable of increasing the survival of transplanted dopa minergic neurons. Although growth factors can exert survival promoting effects when added to the graft prep aration (93, 131, 151) , it may be more effective to supply the trophic factor to the graft not only during preparatory stages (phase 2, Fig. 1 ) but also once it has been trans ferred to the host brain (phases 3 and 4 , Fig. 1 ).
CONCLUDING REMARKS
The past 5 years have seen considerable advances re garding our understanding of when and how grafted do paminergic neurons die, and also on different methods to improve their survival. One ultimate goal of these studies is the development of a clinical protocol that re quires that only one human donor embryo is necessary for each transplant recipient patient. This would require an increase in the survival beyond that observed so far with any single one of the treatments described in this review. Needless to say, such a protocol must use drugs/ growth factors and a delivery technology that are safe in a clinical setting.
Currently there appear to exist three main options when trying to attain the goal of "one donor-one pa tient." First, it is possible to continue to search for better neuroprotective agents, although it is not certain that there exist more effective compounds. Second, it is valid to test combinations of treatments already found to be effective, but it is unlikely that effects will be additive in many cases. It seems that the combinations that are most likely to exert additive, positive effects are those that bring together factors with principally different modes of actions, such as antioxidants and anti-apoptotic agents. Third, increased emphasis should be placed on understanding the changes in the host brain that take place during graft implantation (phase 3, Fig. 1 ) and in hibiting their detrimental effects on transplant survival.
With several active research groups contributing to all of these options, there is cause for optimism for the future.
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